[1]
B. Swathi, D. Bhavika, and N. Begum, “Adverse drug reaction profiles of commonly used platinum compounds in cancer chemotherapy”, Int J Basic Clin Pharmacol, vol. 4, no. 2, pp. 284–289, Jan. 2017.